当前位置:首页 - 行情中心 - 明德生物(002932) - 财务分析 - 利润表

明德生物

(002932)

57.60

-0.58  (-1.00%)

今开:58.20最高:58.46成交:2.05万手 市盈:0.00 上证指数:2797.48   2.50%2018-09-21
昨收:58.18 最低:57.00 换手:0.00%振幅:0.00 深证指数:8409.18  2.13%15:02:03

集合

竞价

利润表

按照会计年度查询:
报告期2018-06-302018-03-312017-12-312017-06-30
一、营业总收入97,895,767.1837,824,801.9165,123,343.783,930,799.6
营业收入97,895,767.1837,824,801.9165,123,343.783,930,799.6
二、营业总成本52,684,780.5621,528,420.2296,784,209.8344,528,216.98
营业成本21,170,457.98,283,610.3229,950,555.413,983,772.88
营业税金及附加843,112.14368,929.291,450,714.1725,163.36
销售费用15,591,261.715,458,828.2328,762,409.1412,935,564.91
管理费用14,531,358.917,359,737.5236,695,507.0716,707,536.34
财务费用37,822.48-166,179.78-558,580.25-316,441.98
资产减值损失510,767.42223,494.64483,604.37492,621.47
三、其他经营收益--------
允许价值变动净收益--------
投资净收益475,945.21--1,453,452.07573,178.09
联营、合营企业投资收益--------
汇兑净收益--------
四、营业利润46,308,586.4916,404,338.3975,663,752.1539,975,760.71
营业外收入----500,0001,027,895.9
营业外支出0.04--737,918.26673,282.49
非流动资产处置净损失--------
五、利润总额46,308,586.4516,404,338.3975,425,833.8940,330,374.12
所得税7,145,060.82,507,383.359,872,017.176,191,251.68
未确认的投资损失--------
六、净利润(百万元)38.7313.6265.4934.13
少数股东损益433,233.11274,228.5661,169.475,233.6
归属于母公司股东的净利润38,730,292.5413,622,726.4865,492,647.2534,133,888.84
七、每股收益0.780.271.310.68
基本每股收益0.780.271.310.68
稀释每股收益0.780.271.310.68
TOP↑